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In the research field of extracellular vesicles (EVs), the use of fetal bovine serum (FBS) depleted of 
EVs for in vitro studies is advocated to eliminate the confounding effects of media derived EVs. EV-
depleted FBS may either be prepared by ultracentrifugation or purchased commercially. Nevertheless, 
these preparations do not guarantee an RNA-free FBS for in vitro use. In this study we address the 
RNA contamination issue, of small non-coding (nc)RNA in vesicular or non-vesicular fractions of FBS, 
ultracentrifugation EV-depleted FBS, commercial EV-depleted FBS, and in our recently developed 
filtration based EV-depleted FBS. Commercially available serum- and xeno-free defined media were 
also screened for small ncRNA contamination. Our small ncRNA sequencing data showed that all EV-
depleted media and commercially available defined media contained small ncRNA contaminants. Out 
of the different FBS preparations studied, our ultrafiltration-based method for EV depletion performed 
the best in depleting miRNAs. Certain miRNAs such miR-122 and miR-203a proved difficult to remove 
completely and were found in all media. Compared to miRNAs, other small ncRNA (snRNA, Y RNA, 
snoRNA, and piRNA) were difficult to eliminate from all the studied media. Additionally, our tested 
defined media contained miRNAs and other small ncRNAs, albeit at a much lower level than in serum 
preparations. our study showed that no media is free of small ncRNA contaminants. therefore, in order 
to screen for baseline RNA contamination in culturing media, RNA sequencing data should be carefully 
controlled by adding a media sample as a control. this should be a mandatory step before performing 
cell culture experiments in order to eliminate the confounding effects of media.
Fetal bovine serum (FBS) contains essential factors required for cell growth, metabolism, attachment, and stim-
ulation of proliferation1. Thus, it is the most widely used supplement for culturing human and animal cells. One 
of the major concerns that has become evident recently is the presence of large amounts of extracellular vesicles 
(EVs) in FBS2–4. Secreted by most cell types, EVs are mediators of cell-to-cell communication and immune reg-
ulation5,6. They carry the genetic material (DNA and RNA) as well as proteins, lipids and other molecules, the 
transfer of which can alter the functions of the recipient cells. EVs present in FBS are co-isolated with cell-derived 
EVs and therefore act as contaminants that, affect the reliability of the read-out from cell culture experiments, as 
FBS-derived EVs are structurally and functionally similar to cell-derived EVs7. In addition, FBS-EVs taken up 
by cultured cells cause substantial physiological effects2. To overcome this problem, different methods are used 
to deplete EVs from FBS. Ultracentrifugation (UC) is commonly used, but this method removes EVs only par-
tially3,4,8. Commercially available depleted FBS are produced using proprietary protocols to reach higher purity 
levels. Also, commercially available defined, serum-free and animal protein free (xeno-free) media developed for 
clinical cell therapy purposes are an alternative to the largely undefined FBS in culture media. However, we and 
others have shown that EV-depleted FBS produced by UC or even commercial EV-depleted FBS are not com-
pletely free of FBS-derived EVs3,4. Recently we have developed a simple, standardized, cost- and time-effective 
protocol to produce EV-depleted FBS by means of ultrafiltration (UF) for cell culture purposes that support cell 
viability and proliferation9.
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In the EV research field, identifying the ‘RNA contaminants’ derived from media itself is of high impor-
tance when developing RNA biomarkers. To address this question, we undertook this study to characterize the 
extracellular small non-coding (nc)RNA contaminants present in FBS, EV-depleted FBS, commercially avail-
able EV-depleted FBS as well as serum- and xeno-free defined media to assess their small ncRNA content and 
diversity.
Results
EV characterization. EVs were isolated from FBS, ultracentrifugation EV-depleted FBS (UC-dFBS), ultra-
filtration EV depleted FBS (UF-dFBS), commercial depleted FBS (SBI-dFBS) and commercial serum- and xeno-
free media (StemPRO) by ultracentrifugation (Table 1). EVs were further characterized by nano tracking analysis 
(NTA), transmission electron microscope (TEM) and western blotting (WB). Based on TEM analysis, while no 
vesicles could be detected in UF-dFBS, vesicles structures and protein aggregates were detected in regular FBS, 
UC-dFBS and SBI-dFBS. StemPRO displayed scarce vesicle-like structures and large protein aggregates (Fig. 1A). 
For western blotting (WB) analysis, bovine specific EV markers are lacking and species cross reactivity for bovine 
is rarely reported. Anti-tetraspanin antibodies were not used as it is difficult to estimate whether these antibodies 
specific for mouse or human samples recognize the bovine form. We therefore selected anti-transferrin receptor/
CD71 H68.4 monoclonal antibody, which is abundant in serum-derived material, suitable for both mouse and 
bovine proteins and also recognizes a transmembrane protein, therefore its detection confirms that EVs are ana-
lyzed10,11. WB results indicated a strong CD71 band in FBS and SBI-dFBS, whereas no bands were detected in 
UC-dFBS and UF-dFBS. Faint band of CD71 protein was detected in StemPRO (Fig. 1B). To address the contam-
ination issue, we also performed an additional WB analysis (Supplementary Fig. 1) with HDL (ApoA1) to assess 
the presence of non-EV bound miRNAs in our samples. Since the antibody was specific for human proteins, 
species cross-reactivity was analyzed running human plasma samples in parallel with FBS samples. No primary 
antibody control was used to assess if any non-specific binding or false positives may be due to non-specific 
binding of the secondary antibody. Pure human HDL was added as a positive control. Thereby confirming the 
reliability of the results.
Characterization of the EV samples by NTA supported the WB results (Fig. 1C–F). The NTA results showed 
that as compared to other FBS and SBI-dFBS (Fig. 1D), the number of particles in StemPRO and UC-dFBS was 
lower, while UF-dFBS had a very low particle count (Fig. 1E). Regular FBS and SBI-dFBS had similar particle 
number (e11) and particle distribution (Fig. 1C). Together, these results indicate that UF-dFBS has a low particle 
and protein content, potentially being nearly EV-free. Next, we wanted to address the small ncRNA content in 
these preparations.
General mapping results of small ncRNA sequencing. Small ncRNA sequencing was performed on 
FBS containing media (regular FBS and EV-depleted FBS) and serum- and xeno-free media (Table 1). RNA 
sequencing was not feasible on basal media and supplements due to low RNA yield. Mapping of our sequencing 
data to human reference genome showed that 0.8 to 9.6 million reads per sample were obtained in the sequencing 
experiments (Fig. 2). No clear pattern in raw read counts was observed with the different depletion treatments, 
Acronym Culture media Basal media Serum manufacturer Serum content Supplementation
Price/50 ml 
(excl. VAT)
FBS-1 FBS-1 media DMEM/F12 + Glutamaxcat# 31331093
Sigma, ref. 10270106, lot. 
42F8554K 10% FBS 1% pen-strep 4 eur
FBS-2 FBS-2 media DMEM/F12 + Glutamaxcat# 31331093
Gibco, ThermoFisher cat# 
10270106
lot. 42G8468K
10% FBS 1% pen-strep 4 eur
UC-dFBS-1 Ultracentrifugation EV-depleted FBS media
DMEM/F12 + Glutamax
cat# 31331093
Sigma, ref. 10270106, lot. 
42F8554K 10% UC-dFBS 1% pen-strep 36 eur
UC-dFBS-2 Ultracentrifugation EV-depleted FBS media
DMEM/F12 + Glutamax
cat# 31331093
Gibco, ThermoFisher cat# 
10270106
lot. 42G8468K
10% UC-dFBS 1% pen-strep 35 eur
UF-dFBS-1 Ultrafiltration EV-depleted FBS media
DMEM/F12 + Glutamax
cat# 31331093
Sigma, ref. 10270106, lot. 
42F8554K 10% UF-dFBS 1% pen-strep 53 eur
UF-dFBS-2 Ultrafiltration EV-depleted FBS media
DMEM/F12 + Glutamax
cat# 31331093
Gibco, ThermoFisher cat# 
10270106
lot. 42G8468K
10% UF-dFBS 1% pen-strep 52 eur
SBI-dFBS-1 Commercial Exosome depleted FBS media
DMEM/F12 + Glutamax
cat# 31331093
System Biosciences, ref. EXO-
FBS-50A-1 lot.170501-001 10% SBI-dFBS 1% pen-strep 39 eur
SBI-dFBS-2 Commercial Exosome depleted FBS media
DMEM/F12 + Glutamax
cat# 31331093
System Biosciences, ref. EXO-
FBS-50A-1 lot.170718-001 10% SBI-dFBS 1% pen-strep 39 eur
StemPRO Commercial StemPro MSC Serum free medium
StemPro® MSC SFM Basal Medium Gibco, Thermo Fisher,A1067501 —
0.3% pen-strep, 1% 
StemPro MSC CFM 
Xenofree supplement, 
GlutaMAX™ Supplement
37eura
Table 1. Suppliers and pricing information of culture media used for small ncRNA sequencing. Pricing information 
include consumables and supplementation needed for preparation of 50 ml of complete media. aculture vessels need 
to be coated with CELLstart™ Substrate (Thermo Fisher cat# A1014201) 1:50 dilution 3.6 eur/ml.
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but samples based on FBS-2 (dFBS-UC-2 and dFBS-UF-2) showed 3- to 10-fold lower raw reads than their FBS-
1-based counterparts.
Mapping of small ncRNA sequencing reads to bovine and human genome displayed indistin-
guishable miRNA reads and non-overlapping small ncRNA reads between the two species. 
Small ncRNA sequencing reads were mapped to both human and bovine genome to detect the extent of 
species-specificity and overlap between the species. Our analysis showed (Fig. 3) that human miRNAs in the 
tested culture media mapped almost completely (90–100%) to bovine miRNAs, which is also consistent with 
previous report4. The similarity between bovine and human miRNAs makes distinguishing bovine miRNAs 
from human miRNA difficult, which may be a confounding factor when assessing miRNA derived from cell cul-
ture experiments. In StemPRO medium the overlap was only 73%, which suggests that a much more significant 
Figure 1. Characterization of EVs isolated by ultracentrifugation. Transmission electron microscopy analysis 
revealed the presence of vesicles in FBS, UC-dFBS and SBI-dFBS. StemPRO contained scarce vesicle-like 
structures and abundant protein aggregates, while no vesicles could be detected in UF-dFBS (A). Western 
blotting (B) displayed strong expression of CD71 in FBS and SBI-dFBS, no expression in UC-dFBS and UF-
dFBS, whereas low expression was detected in StemPRO. Expression of HDL was seen in all samples except UF-
dFBS. Nano tracking analysis (C–F) indicated that UF-dFBS had the lowest particle count. Particle distribution 
(C–F). (C) D10 = 10% of particles are below the size indicated as D10, D50 = 50% of particles are below the size 
indicated as D50, D90 = 90% of particles are below the size indicated as D90. Median particle size in FBS, dFBS 
and UC-FBS are in a similar range, while UF-dFBS is considerably different. (D,E) Particle concentration and 
distribution. FBS and SBI-dFBS showed similar particle concentrations. (F) X-axis; particle size (nm) in two size 
ranges; 50–200 nm and 200 + nm.
Figure 2. Overview of sequencing data and mapping to human reference genome. Number of counts mapped 
to miRNA, other small ncRNA (tRNA fragments, snRNA, Y RNA, snoRNA or piRNA) for each sample are 
shown. Genome-mapped refers to reads that aligned to the human reference genome outside small ncRNA loci. 
Outmapped counts were mapped to adapters, rRNA, mtRNA or polyA/polyC homopolymers.
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proportion of these reads may not have originated from miRNA at all, but may rather be experimental noise, sug-
gesting that the actual miRNA content of the defined media was very low. In contrast to miRNAs, other human 
small ncRNAs were also mapped to a high degree (90–100%) to the bovine genome. The reason for this is that the 
database for bovine small ncRNAs did not contain any tRNA fragments, which made up most of the human small 
ncRNA alignments. Therefore, almost all human small ncRNA reads were classified as mapping to the bovine 
genome instead of mapping to small ncRNAs.
Vesicular and non-vesicular derived small ncRNA contaminants in FBS, dFBS and commercial media. 
We further characterized the small ncRNA composition of FBS media preparations. As a quality control, serum 
and xeno-free media (StemPRO) was included in the study and evaluated for RNA contamination, as this medium 
should not contain any animal derived components. To facilitate comparison between different media types, total 
miRNA and other small ncRNA levels were normalized according to the external spike-in levels. As shown in 
the Fig. 4, StemPRO contained small amounts of small ncRNA, source of which is not clearly known. As shown 
in Fig. 4, considerable variation was observed in RNA content between different media types and manufacturers. 
In untreated FBS, most (93%) of all small ncRNA counts were mapped to tRNA, whereas 6.5% were mapped to 
miRNA. Other types of small ncRNA (snRNA, Y RNA, snoRNA, piRNA) were detected in only small amounts 
(<0.2%). As expected, highest levels of miRNA were detected in untreated FBS, whereas commercial SBI-dFBS 
had 60 ± 20% lower total miRNA counts. Ultracentrifugation and ultrafiltration lowered the total miRNA content 
by 80 ± 9% and 99.8 ± 0.1%, respectively. Commercial serum-free medium StemPRO had 99.95 ± 0.01% lower 
total miRNA content than FBS. For tRNA and snRNA, a similar clear trend was not observed, and depleted media 
had similar levels of tRNA and snRNA as untreated FBS, although large variation between individual samples was 
observed (Fig. 4). For Y RNAs and snoRNAs, approximately 10-fold reduction was observed in UF-dFBS com-
pared to other FBS-based media. StemPRO had very low levels of any kind of small ncRNAs. Full list of spike-in 
normalized miRNA and other small ncRNA counts are listed in Supplementary 1. It should be noted that since 
the spike-ins used were miRNA-sized (20–24 nt), the normalization is likely to be more accurate in the case of 
miRNAs than other small ncRNA, which were mostly longer (~30 nt).
For depicting the overlap of small ncRNAs in the different media, Euler diagrams were created (Fig. 5). Our 
data showed that almost all of the detected miRNAs were found in FBS (109 miRNA detected). Only one miRNA, 
miR-133a-3p, was not detected in FBS or FBS-derived media, but only in commercial SBI-dFBS media. As 
expected, all the miRNAs in depleted media were also found in untreated FBS. EV depletion techniques resulted 
in lower number of miRNAs detected above threshold: 68 for SBI-dFBS, 36 for UC-dFBS and only 1 for UF-dFBS. 
Similar pattern was observed for other small ncRNA, with all the RNAs detected in FBS-based depleted media 
also present in untreated FBS and 40 unique tRNA fragments and one Y RNA found in SBI-dFBS media. Less 
effective depletion was observed with tRNA, snRNA, Y RNA and snoRNA, with UF-dFBS still containing 87 out 
of the 178 tRNA, 10 out of 18 snRNA and 2 out of 8 Y RNA detected in untreated FBS.
Comparative analysis of RNA depletion efficiency. Subsequently, we evaluated the RNA depletion effi-
ciency of different EV depletion methods. Unsupervised clustering analysis (Fig. 6A) showed that in the case of 
miRNAs, sample types clustered together, and a uniform decrease in miRNA levels across almost all miRNAs was 
Figure 3. Overlap in alignment to human and bovine reference genomes. Reads aligned human small ncRNAs 
(miRNA and other ncRNA) were further mapped to a bovine reference genome to estimate the likelihood that 
these RNAs are of bovine origin. Genome refers to reads that aligned to the bovine reference genome outside 
small ncRNA loci. Un/outmapped reads either failed to map or were mapped to adapters, rRNA, mtRNA or 
polyA/polyC homopolymers.
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Figure 4. Spike-in normalized concentration of different small ncRNA in studied media. Total miRNA, 
tRNA, snRNA, Y RNA, snoRNA, and piRNA concentration is shown for each media sample. Error bars depict 
standard deviation of the spike-in fit.
Figure 5. Euler diagrams showing the relationships of the small ncRNA sets detected in different media types. 
RNAs detected at above 1 spike-in normalized count level (moderate to high abundance) were included in the 
diagrams. Total number of different RNAs per media type are shown in parenthesis. No small ncRNAs were 
detected above this level in the StemPRO sample.
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observed with the depletion treatments. hsa-miR-122–5p was clearly the most abundant miRNA in FBS-based 
media. Furthermore, we also investigated how many of the top 20 most commonly reported EV miRNAs in 
the literature are present in different media preparations (Supplementary 2, table B). Several of the commonly 
reported miRNA in EVs like hsa-miR-21-5p, hsa-miR-451a, hsa-miR-16-5p, hsa-let-7a, hsa-let-7b and hsa-miR-
93-5p has-miR-93-5p were found in high levels even in some of the depleted media preparations. In contrast, 
clustering based on other small ncRNAs (Fig. 6B) occurred based on FBS supplier (1 and 2; Table 1) rather than 
sample type. No clear reduction in tRNAs was observed by the depletion treatments. This indicated that tRNA, 
Figure 6. Unsupervised clustering analysis of the most abundant miRNAs (A) and other small ncRNAs (B). 
Top 60 most abundant miRNAs and top 40 most abundant other small ncRNAs in any samples were selected 
for the clustering analysis, resulting in 101 miRNAs and 109 other small ncRNAs. Heatmaps are showing 
the relative concentration of each RNA, normalized using the spike-in miRNAs. Medium level refers to the 
concentration range of spike-ins, whereas low level is lower than any of the spike-ins and high level is higher 
than any of the spike-ins used.
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which were the most abundant type of small ncRNA detected in the media samples, was not effectively removed 
with the depletion treatments. However, a large difference in tRNA levels was observed between the two FBS 
suppliers tested.
Enrichment of mir-203a in all media. The sequencing data clearly indicated ineffective depletion of RNA 
in dFBS, commercially available EV-depleted FBS and defined media, and the efficiency of miRNA depletion in 
these depleted media is unclear. To address this, we focused on specific miRNAs and traced their levels in the 
different media preparations. Based on the clustering analysis, two groups of miRNAs were selected for further 
analysis; miRNAs strongly affected by depletion methods and miRNAs weakly affected by depletion methods 
(Supplementary 2, figure). As can be seen, there is little difference between the groups, indicating that almost all 
the miRNAs are similarly affected by the depletion methods. A notable exception is hsa-miR-203a, which was 
present in StemPRO and appeared to be unaffected by all of the depletion methods.
Discussion
Interference by FBS derived RNA (vesicular or non-vesicular) in the in vitro studies has recently become evi-
dent2–4, Therefore, reliability of the results depends on the complete elimination of serum derived RNA. Until 
now, little attention has been paid to characterizing these RNA contaminants. Ultracentrifugation, the standard 
method used for EV depletion, is unable to provide EV-free FBS. Moreover, commercially available EV-depleted 
FBS are also not completely EV/RNA-free9. Therefore, we recently developed an ultrafiltration-based protocol to 
generate EV-free serum. Consequently, we undertook this study to define the small ncRNA contamination pres-
ent in different depleted FBS preparations, including our ultrafiltration-based EV- depleted FBS, commercially 
available EV-depleted FBS and serum- and xeno-free media.
It is well known that the specificity of isolating EVs is low for both ultracentrifugation and other EV isolation 
methods. Various studies have demonstrated that EV preparations derived using these methods contain small 
amounts of non-EV soluble components, which might carry RNA as well12–14. EV isolation and RNA sequencing 
was done according to the stringent workflow of the Qiagen services. Furthermore, qPCR was performed on our 
media samples with endogenous miRNAs (miR-451a, miR-103a-3p, miR-191-5p, miR-23a-3p, miR-30c-5p, mir-
23a-mir451a and 3 spike in controls; UniSp6, UniSp-101, and UniSp-100). mir-451a, used as an EV marker15, 
was clearly expressed in our samples, indicating that miRNAs analyzed are EV related. Despite using a stringent 
protocol for isolating EV-related RNA for RNA sequencing, we still could not rule out the possibility of presence 
of non-vesicular RNA in our data. As the genuine association of sequenced RNA with EVs was not demonstrated 
(by using differential nuclease/protease and detergent treatments, for instance) in our study due to technical dif-
ficulties, it is more likely that our samples contained both “cell-free RNA” (non-vesicular RNA) and “EV-bound 
RNA” (vesicular RNA). Therefore we prefer to use the term “vesicular or non-vesicular fractions” in this study.
A vast majority of miRNAs (90–95%) are estimated to be non-vesicular16,17. Based on information retrieved 
from the literature, similar trend was observed for our miRNA data (Supplementary 2, table A). A possible source 
of miRNA contamination could be the circulating miRNA bound to various carriers, including Argonaute2 
complexes, albumin and lipoproteins. Since high density lipoprotein (HDL) HDL-miRNA transport appears to 
be more robust than low density lipoprotein (LDL)18, we focused on analyzing HDL (ApoA1) in our samples. 
As expected, all the samples except UF-dFBS showed positive expression of HDL, indicating that none of the 
EV-depleted media are EV or lipoprotein free. These HDL-associated miRNA, could be considered as one of the 
source of miRNA contamination.
Our data was in agreement with Wei et al.4, where 100% overlap of RNA sequencing between bovine and 
human genome was observed. These results indicate, that media selected for cell culture experiments should be 
chosen carefully, prioritizing EV/RNA-free media. Screening of contaminants from the culture media should be 
a routine procedure in order to establish the baseline level of RNAs as a control to minimize the confounding 
effect of media. To highlight the importance of these findings, we collected the most commonly reported miR-
NAs in cell-culture-based EV studies (Supplemental 2, table B) and observed their levels in different media types. 
Majority (15 out of 20) of the most commonly reported miRNAs were found in moderate to high levels, while 5 
out of 20 were found in very high levels.
UF-dFBS showed an exceptional performance in depleting miRNAs compared to UC-dFBS and SBI-dFBS. 
Surprisingly, miRNA levels in commercially available SBI-dFBS were slightly higher than UC-dFBS, and some 
miRNA, such as miR-122-5p and miR-203a were present in at least moderate levels in all dFBS. miR-122-5p was 
also recently reported to be present in abundant amounts in FBS and dFBS, which indicates that certain miR-
NAs are difficult to remove completely. In the case of miR-122-5p, this is due to its high abundance in FBS. Even 
though more than 99% is removed, moderate levels are still left in UF-dFBS. Liver specific miR-122 is exclusively 
non-vesicular, with key roles in hepatocyte growth, metabolism, and homeostasis19. miR-122 is also associated 
with human liver cancer metastasis and lung cancer20.
It is difficult to explain the inefficiency of removing miR-203a. It was detected mainly as short, 16-nt inserts, 
and could potentially be an experimental artifact, which would explain its presence in all the samples, even in 
StemPRO. It has been reported that miR-203 has an effect on many properties of cells in culture, e.g. as an inhibi-
tor of ‘stemness’ of mammary stem cells and pluripotent stem cells and it may also have anti-tumorigenic activity 
in cancer stem cell populations21–24.
One striking observation in our study is that other small ncRNA (snRNA, Y RNA, snoRNA, and piRNA) 
contaminants are clearly more difficult to eliminate, even with our UF-dFBS (Figs 4 and 6). Despite being fully 
defined, StemPRO media was not completely RNA free, small traces of both miRNA and small ncRNA were 
detected. This is an important point to consider, as these GMP produced media are intended for clinical stem cell 
therapy.
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Regardless of its source, presence of RNA (vesicular/non-vesicular) in all the tested media should still be con-
sidered contamination, which needs careful consideration for further applications. While there is no data readily 
available, we speculate that possible source of the RNA in these media could be from the recombinant proteins 
such as human serum albumin, essential amino acids, or vitamin constituents25,26.
It is likely that RNA detected in our study could have originated from the different components of media sup-
plements. In the future additional studies are needed to formulate an RNA free culture media, where all media 
components should be precisely screened. This will provide the details about the function and origin of the dif-
ferent RNA components in media.
In conclusion, our results highlight the need and importance of screening of EV- and RNA-free media for the 
in vitro studies in the EV field, specifically related to the investigation of RNA biomarkers. Furthermore, functional 
impact of these contaminant RNA in recipient cells need to be addressed to understand their biological roles.
Materials and Methods
FBS. FBS was obtained from two different suppliers, product details are described in Table 1. FBS obtained 
from Sigma was referred as FBS-1 and from Gibco as FBS-2.
EV-depleted FBS preparations. EV-depleted FBS was prepared from both FBS-1 and FBS-2. 
Ultracentrifugation and ultrafiltration were used to deplete EVs from FBS. The preparation of UC-dFBS and 
UF-dFBS from regular FBS was done according Kornilov et al.9. Briefly, UC-dFBS was prepared by 19 hours UC 
of regular FBS at 26,000 rpm (121 896 gmax) with SW28 rotor (k-factor 284.7, Beckmann-Coulter). Light-colored 
top layer of supernatant was filtered with a 0.22 µm filter (Millipore Stericup-GP, 0.22 µm, polyethersulfone filter). 
UF-dFBS was prepared by centrifuging regular FBS for 55 min at 3,000 g in Amicon ultra-15 centrifugal filters 
(ref: UFC910024, 100 kDa Merck Millipore Ltd., Tullagreen, Carrigtwohill, Co. Cork, Ireland) and collecting of 
flow-through. FBS-1, UC-dFBS-1 and UF-dFBS-1 refer to FBS obtained from Sigma and FBS-2, UC-dFBS-2 and 
UF-dFBS-2 refer to FBS obtained from Gibco (Table 1). Commercially available EV-depleted FBS (Exo-FBS™, 
System Biosciences, EXO-FBS, Mountain View, CA, USA), termed as SBI-dFBS, was used as a control (Table 1). 
Flowchart of the study design is illustrated in Fig. 7.
Defined media. StemPRO® MSC SFM medium, a fully defined media formulation for culturing mesen-
chymal stem cells, was used as a serum-free, xeno-free culture media control. For media supplementation, see 
Table 1.
EV isolation from FBS preparations and defined media. EV characterization was performed on EVs 
isolated by UC due to technical issues related to using exoRNeasy Serum/Plasma Maxi Kit (Qiagen) used for the 
sequencing study. This issue has been described in our previous article27 Briefly, EVs were isolated from 10 ml 
of FBS, UC-dFBS, UF-dFBS, SBI-dFBS, and StemPRO by ultracentrifugation for 2 hours at 26,000 rpm (121 896 
gmax, SW28 rotor, 4 °C) to collect an EV pellet, which was washed with filtered DPBS (0.1 μm filter) and stored 
in Protein LoBind microcentrifuge tubes (Eppendorf) at −80 °C. For small ncRNA sequencing, EVs and RNA 
were isolated from 3.5 ml of FBS, UC-dFBS, UF-dFBS, SBI-dFBS, and StemPRO by exoRNeasy Serum/Plasma 
Maxi Kit (Qiagen).
Nanoparticle tracking analysis. The number and size distribution of particles in EV samples were 
analysed using NTA (Nanosight LM14, NanoSight Technology, Salisbury, U.K., http://www.malvern.com) as 
described previously9. Briefly, isolated EVs were diluted in filtered (0.1 µm) DPBS to obtain the optimal detection 
concentration of 106–109 particles/ml, and triplicate videos were recorded. The data was analysed using NTA 
software28.
transmission electron microscopy. Particle morphology was examined using TEM as described pre-
viously9,28. Briefly, isolated EVs were diluted in filtered (0.1 µm) DPBS, loaded into 200 mesh copper grids and 
negatively stained with neutral uranyl acetate and embedded in methyl cellulose uranyl acetate mixture.
Western blotting. WB was performed as described previously9 using primary antibodies against 
anti-transferrin receptor/CD71-H68.4 (#13-6800, Thermofisher Scientific) at 1:1000 dilution and ApoA129,30 
(kind gift from Matti Jauhiainen) at 1:2000 EVs isolated by ultracentrifugation from equal volumes (20 ml) 
of each sample were loaded to gels. As a control, protein from adipose tissue derived mesenchymal stem cell 
lysates were used. Samples were denatured at 95 °C for 5 min in reducing Laemmli sample buffer, separated using 
Mini-PROTEAN® TGX™ 12% gradient SDS-PAGE gel (#456-1043, Bio-Rad) with BlueSTAR Prestained Protein 
Marker (#MWP03, Nippon Genetics Europe GmbH) as a standard. Running conditions were 150 V for 60 min-
utes. Blotting involved semi-dry transfer of proteins on nitrocellulose membranes, 0.2 µm (#162-0112, Bio-Rad), 
using 40 mA per gel for 60 minutes. Blocking and antibody incubations were performed in Odyssey blocking 
buffer (PBS) (#927-40000, LI-COR) with and without 0.1% Tween-20, respectively. After primary antibody over-
night incubation at +4 °C, membranes were washed 4 × 5 minutes in TBS-T and probed with secondary IRDye® 
800CW Goat (#925-32210, LI-COR) at 1: 15,000 and goat anti-rabbit (#925-32210, LI-COR) at 1:10000 for 1 hour 
at room temperature (RT). After incubation, membranes were washed 4 × 5 minutes in TBS-T at RT and briefly 
rinsed with PBS 1X, then imaged on an Odyssey FC Imager (LI-COR).
Small non-coding RNA (small ncRNA) sequencing. Small ncRNA sequencing was performed by Qiagen 
(Qiagen, Hilden, Germany). EVs and RNA were isolated using exoRNeasy Serum/Plasma Maxi Kit. EVs were 
isolated from 3.5 ml of media followed by RNA isolation protocol optimized for serum/plasma (no carrier RNA 
was added). Library preparation was done using the QIAseq miRNA Library Kit. Out of 12 µl of isolated RNA, 5 µl 
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was converted into microRNA NGS libraries. Adapters containing 12nt-long unique molecular indices (UMIs) 
were ligated to the RNA. Then RNA was converted to cDNA. The cDNA was amplified using PCR (22 cycles) and 
during the PCR indices were added. After PCR the samples were purified. Library preparation quality control 
was performed using either Bioanalyzer 2100 (Agilent) or TapeStation 4200 (Agilent). Based on the quality of 
the inserts and the concentration measurements the libraries were pooled in equimolar ratios. The library pools 
were quantified using the qPCR ExiSEQ LNA™ Quant kit (Exiqon). The library pools were then sequenced on a 
NextSeq500 sequencing instrument according to the manufacturer instructions using 1 × 75 bp reads. Raw data 
was demultiplexed and FASTQ files for each sample were generated using the bcl2fastq software (Illumina Inc.).
Data analysis. UMI correction and trimming. To correct PCR bias with UMI information, raw reads were 
processed as follows: First, cutadapt 1.1131 was used on each raw read with the adapter sequence to acquire infor-
mation about the presence of adapter. Only reads that fulfilled the following criteria were kept: (1) read contained 
adapters, (2) read had at least 16nt insert sequence length, and (3) read had at least 10nt-long UMI sequence. 
Second, insert sequences with incomplete UMI sequence were extracted as partial-UMI reads. Third, all unique 
insert + UMI combinations were identified from reads with full-length UMI and collapsed into a single read. 
Fourth, collapsed full-length UMI reads and partial-UMI reads were combined. After UMI-correction, reads 
were trimmed using cutadapt output and an in-house script.
Mapping. Reads were mapped using Bowtie 2 (2.2.2)32 as follows: First, reads mapped to spike-ins or outmapped 
(mapped to adapter sequences, polyA and polyC homopolymers, or abundant ribosomal or mitochondrial RNA 
Figure 7. Flowchart of the study design. EV depleted FBS was prepared by ultracentrifugation, ultrafiltration 
or purchased from commercial supplier. Detailed protocol for the preparation of EV depleted FBS is described 
in materials and methods section. EVs extracted by ultracentrifugation from 10 ml of FBS, EV depleted FBS and 
commercial defined media were characterized by NTA, TEM and WB. For small ncRNA sequencing, EVs and 
RNA were extracted using exoRNeasy Serum/Plasma Maxi Kit (Qiagen) from 3.5 ml of media containing 10% 
depleted FBS. Reads were mapped to both bovine and human genome and media derived small ncRNA were 
identified.
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sequences) were filtered out. Perfect match to the reference sequence was required. Second, reads were aligned 
to mature sequences of miRBase 20, requiring perfect matches. Third, unmapped reads were mapped to either 
to human GRCh37 or bovine UMD3 reference genome, allowing one mismatch in the first 32 bases of the read. 
Reads aligned to known miRNA loci in the genome were combined with the miRBase-mapped reads and reads 
aligned to small ncRNA reqions in the Exiqon small ncRNA database were classified as small ncRNA. Reads map-
ping to the reference genome outside the miRNA or small ncRNA regions were classified as genome-mapped. No 
indels were allowed in any of the mapping steps.
Statistical analysis. Read counts were normalized using the external spike-ins (UniSp100–UniSp151) that were 
present in three relative concentrations of 0.1 (low), 1 (moderate) and 5 (high), reflecting the expected range of 
miRNAs in the samples. Linear functions with intercept fixed at zero were fitted to the spike-in concentration 
versus observed counts in each sample. The linear fit was used calculate an estimated relative concentration for 
each RNA. For the clustering analysis, only RNAs with moderate (>1) spike-in normalized counts in at least one 
sample were included. Clustering analysis was performed on lists of miRNAs and small ncRNAs, which included 
the top 60 most abundant miRNAs and 40 most abundant small ncRNAs in all samples. Euclidean distance met-
ric and average linkage were used in the unsupervised clustering analysis. Euler diagrams were created using a 
threshold of 1 spike-in normalized counts (moderate to high abundance) using the eulerr-package in R.
Identifying commonly reported miRNAs. To identify most commonly reported EV miRNAs in cell culture stud-
ies, we used EVpedia33 and miRandola34 databases. Studies using human cultured cells were included. In miRan-
dola, only studies with exosome or microvesicle material were included. This resulted in 19 included studies in 
EVpedia and 10 studies in miRandola. Three studies were reported in both databases, resulting in a total of 26 
studies (Supplementary 2, table B).
Data Availability
The RNA sequencing data has been deposited to the GEO (accession number GSE120594).
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